THE BLUE S.O.S. LLC – Trademark Portfolio

Entity Type: 16

THE BLUE S.O.S. LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DIPLOMASEA. The owner is based in Bronxville, NY.

Bronxville, NY 10708

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

THE BLUE S.O.S. LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

25
Clothing (1 filing)

Clothing, footwear, headgear

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does THE BLUE S.O.S. LLC have?

THE BLUE S.O.S. LLC has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does THE BLUE S.O.S. LLC file in?

THE BLUE S.O.S. LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 25 (Clothing), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What are THE BLUE S.O.S. LLC's most well-known trademarks?

THE BLUE S.O.S. LLC's registered trademark portfolio includes well-known marks such as DIPLOMASEA. These are among 1 currently registered trademark in the portfolio.

What is THE BLUE S.O.S. LLC's trademark registration success rate?

THE BLUE S.O.S. LLC has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.